U.S. Markets open in 3 mins.

Merck & Co., Inc. (MRK.BA)


Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
104.250.00 (0.00%)
At close: 4:07PM ART

Merck & Co., Inc.

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States
908-740-4000
http://www.merck.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees67,455

Key Executives

NameTitlePayExercisedAge
Mr. Kenneth C. FrazierChairman, Chief Exec. Officer and Pres4.35M17.56M62
Mr. Robert M. Davis J.D.Chief Financial Officer and Exec. VP of Global Services3.45MN/A50
Mr. Michael J. HolstonExec. VP and Gen. Counsel1.65M988.03k55
Dr. Roger M. Perlmutter M.D., Ph.D.Exec. VP and Pres of Merck Research Laboratories2.52MN/A65
Mr. Adam H. SchechterExec. VP and Pres of Global Human Health2.23M1.81M52
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ARS.

Description

Merck & Co., Inc. provides healthcare solutions worldwide. It operates in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases. It also offers neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments for acute and chronic otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; fluralaner products to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It has collaboration agreements with Aduro Biotech, Inc.; Premier Inc.; and Cancer Research Technology. The company serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Corporate Governance

Merck & Co., Inc.’s ISS Governance QualityScore as of July 1, 2017 is 1. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 2; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.